Multiple Cranial Neuropathies and Pachymeningitis in a Patient With a Pathogenic Nucleotide-Binding Oligomerization Domain 2 Polymorphism
Authors:
- John BohnsackJBJohn Bohnsack
- Alison CrumACAlison Crum
- Kathleen DigreKDKathleen Digre
- Bradley KatzBKBradley Katz
- Meagan SeayMSMeagan Seay
- Edward QuigleyEQEdward Quigley
- Sean KennedySKSean Kennedy
- Nick MamalisNMNick Mamalis
- Judith WarnerJWJudith Warner
- 1 December 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 41 (4) , 547-552
Abstract
An 11-year-old boy presented with 2 weeks of intermittent headache, right orbital pain, and constant diplopia. Brain MRI showed dural thickening and enhancement of the right lateral cavernous sinus, right orbital apex, and tentorium. Initial cerebral spinal fluid analysis showed only mild pleocytosis, and serum diagnostics were unrevealing. The working diagnosis was Tolosa-Hunt syndrome. His pain and sixth nerve palsy resolved with corticosteroids. Five months after initial presentation, he developed new numbness of the right cheek, complete right ophthalmoplegia, and weakness and numbness of his right hand and leg, all of which were responsive to steroids. Fifteen months later, he returned to the emergency department with 2 weeks of left-sided headaches and acute diplopia. On examination, he had a left cranial nerve 6 palsy. Dural biopsy showed diffuse mononuclear inflammatory cell reaction consisting mostly of lymphocytes with no signs of granuloma formation, nor any epithelioid or giant cells. His clinical course was consistent with an autoinflammatory condition of unknown etiology. Genetic testing with an immunodeficiency panel showed a risk allele in NOD2 (nucleotide-binding oligomerization domain 2) c.3019dup (p.Leu1007Prof*2) that is associated with an increased risk for Crohn disease. His clinical condition had similarities to central nervous system sarcoidosis. Because of the similarities between our patient's clinical, imaging, and genetic findings and neurosarcoidosis, he was switched to a more targeted therapy—infliximab. His condition has since been stable for nearly 2 years. In conclusion, genetic testing should be considered in patients with suspected occult autoimmunity.Keywords
This publication has 13 references indexed in Scilit:
- A Systematic Analysis of Treatment and Outcomes of NOD2-Associated Autoinflammatory DiseaseThe American Journal of Medicine, 2017
- NOD2-associated autoinflammatory disease and immune deficiencyThe Journal of Allergy and Clinical Immunology: In Practice, 2016
- Isolated paediatric neurosarcoidosis presenting as epilepsia partialis continua: A case report and review of literatureEuropean Journal of Paediatric Neurology, 2013
- Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutationsJournal of the American Academy of Dermatology, 2013
- Infliximab as long-term maintenance in steroid-resistant and recurrent sarcoidosis in a renal transplant with central nervous system involvementClinical Kidney Journal, 2012
- Presentations and outcomes of neurosarcoidosis: a study of 54 casesQJM: An International Journal of Medicine, 2009
- Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteriaInflammatory Bowel Diseases, 2008
- Imaging Manifestations of NeurosarcoidosisAmerican Journal of Roentgenology, 2004
- Neurosarcoid Presents Differently in Children Than in AdultsPediatrics, 2003
- Central nervous system sarcoidosisdiagnosis and managementQJM: An International Journal of Medicine, 1999